Navigation überspringen
Universitätsbibliothek Heidelberg
Standort: ---
Exemplare: ---
 Online-Ressource
Titel:Modern CNS Drug Discovery
Titelzusatz:Novel Therapeutics for Psychiatric and Neurological Diseases: From Target Identification to Regulatory Approval
Mitwirkende:Schreiber, Rudy [HerausgeberIn]   i
Verf.angabe:edited by Rudy Schreiber
Ausgabe:2nd ed. 2024.
Verlagsort:Cham
 Cham
Verlag:Springer Nature Switzerland
 Imprint: Springer
E-Jahr:2024
Jahr:2024.
 2024.
Umfang:1 Online-Ressource(XIX, 445 p. 80 illus., 63 illus. in color.)
ISBN:978-3-031-61992-2
Abstract:This new edition is a comprehensive guide to the intricate world of drug discovery and development. It provides readers with an update on basic and novel concepts, approaches and technologies that are used in the discovery and development of new therapeutics for diseases of the central nervous system (CNS). A major aim is to support the education of professionals and specialists in the biomedical neurosciences that will become the innovators, entrepreneurs, and leaders of the future. The educational focus is now enhanced by the inclusion of over 150 study questions available in the free Springer Nature Flashcard App, which makes this a unique book in its field. Divided into five sections, the book starts by introducing concepts and ideas to inspire the next generation of life scientists pursuing careers in drug discovery for CNS diseases. In the following section, key strategies and methods for identifying and testing novel drug targets are described. New chapters on important topics have been added, that is, the blood brain barrier, mass spectrometry, biased signaling and the exposome. The third section highlights strategies and technologies in translational CNS drug discovery and looks at safety and drug metabolism assessment, imaging techniques and functional testing to investigate drug treatment outcomes. The chapters in the fourth section address the emergence of transdiagnostic approaches as exemplified by the Research Domain Criteria initiative and non-invasive brain stimulation techniques. Finally, the book concludes with the late stages of drug development, such as the planning and performance of clinical trials, and regulatory approval. Written by experts from academia and industry, the book covers important fundamentals and best practices as well as current developments in neurotherapeutic research. It offers in-depth insights into the world of drug development and is essential reading for young scientists who are interested in translational research and want to prepare for an academic or industry career in CNS drug discovery.
DOI:doi:10.1007/978-3-031-61992-2
URL:Resolving-System: https://doi.org/10.1007/978-3-031-61992-2
 DOI: https://doi.org/10.1007/978-3-031-61992-2
Datenträger:Online-Ressource
Sprache:eng
Bibliogr. Hinweis:Erscheint auch als : Druck-Ausgabe
 Erscheint auch als : Druck-Ausgabe
K10plus-PPN:1913346714
 
 
Lokale URL UB: Zum Volltext
 
 Bibliothek der Medizinischen Fakultät Mannheim der Universität Heidelberg
 Klinikum MA Bestellen/Vormerken für Benutzer des Klinikums Mannheim
Eigene Kennung erforderlich
Bibliothek/Idn:UW / m4644153818
Lokale URL Inst.: Zum Volltext

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/69286605   QR-Code
zum Seitenanfang